InVivo Therapeutics (NSDQ:NVIV) said today it added Philadelphia’s Hospital of the University of Pennsylvania as a site in the Inspire study of its neuro-spinal scaffold, bringing the total number of sites up to 20. The Cambridge, Mass.-based company’s neuro-spinal scaffold is surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve […]
Spine
Medtronic touts 7-year follow-up data on 2-level Prestige LP disc
Medtronic (NYSE:MDT) today released 7-year follow-up data from a study of its 2-level Prestige LP cervical disc, touting favorable clinical outcomes and patient satisfaction with the system. Medtronic touts the study as the longest patient follow-up data ever for U.S. 2-level cervical disc patients. The data was presented at the 84th Annual Meeting of the American […]
NuVasive beats earnings number despite slide to Q1 red
NuVasive Inc. (NSDQ:NUVA) managed to eke out an earnings beat despite putting red ink in the ledger during the 1st quarter, sending share prices up today on Wall Street. San Diego-based NuVasive posted losses of -$8.9 million, or -18¢ per share, on sales of $215.1 million for the 3 months ended March 31, amounting to an […]
Fourth patient converts from complete to incomplete spinal cord injury in InVivo trial
InVivo Therapeutics (NSDQ:NVIV) said today 4th patient in the Inspire study of its Neuro-Spinal Scaffold has improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury. The Cambridge, Mass.-based company’s neuro-spinal scaffold is surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. […]
Si-Bone touts maintained results at 2 years in iFuse study
Si-Bone this week released 2-year results from the SIFI trial of iFuse implant system designed for sacroiliac joint fusion procedures, touting improvements in quality of life and a 28% reduction in opioid use. Results from the trial were published in The International Journal of Spine Surgery, the San Jose, Calif.-based company said. The 172-patient multi center […]
Bone Biologics closes $5.8m round
Regenerative orthobiologic company Bone Biologics said it recently closed a $5.75 million round joined by the Musculoskeletal Transplant Foundation, Orthofix (NSDQ:OFIX) and Hankey Capital to support development of its bone graft substitute. Boston-based Bone Biologics is developing Nell-1, a bone growth factor designed to be an alternative to other bone growth factors used in surgical procedures such […]
Patient enrolled in InVivo Therapeutics trial succumbs to injuries
InVivo Therapeutics (NSDQ:NVIV) said today that the 8th patient enrolled in a clinical trial of its spinal scaffold succumbed to his injuries nearly 5 days after a severe car accident. The death appears to be unrelated to InVivo’s bioresorbable neuro-spinal scaffold, which is designed to help heal traumatic spinal cord injuries. The patient was implanted April 12 with […]
FDA approves new leads for Nevro’s Senza spinal cord stimulator
Nevro Corp. (NYSE:NVRO) said it won pre-market approval from the FDA for new surgical leads designed to be used with its Senza spinal cord stimulation device. The Senza device, which won an FDA nod in May 2015, is designed to deliver high-frequency electrical impulses of up to 10,000Hz to the spinal cord to avoid the tingling sensation […]
Sen. Franken pushes for review of Medtronic Infuse study
Senator Al Franken (D-Minn.) is pushing for more details on Medtronic‘s (NYSE:MDT) study of its Infuse Bone Graft, saying that the product may have “potentially skewed the risk profile” for patients and exposed “insufficient vigilance” by the FDA, according to the Minneapolis Star Tribune. The senator raised these concerns in a letter to both Medtronic […]
Eos Imaging wins FDA nod for spineEos 3D planning solution
EOS Imaging (EPA:EOSI) said it won pre-market approval from the FDA for its spineEos 3D planning software for spinal surgeries. Paris-based Eos won CE Mark approval in the European Union in February for the system, which is designed to use 3D imaging to create optimized treatment plans for pediatric patients with scoliosis and adults with […]
Stryker spree continues with SafeWire asset buy
Stryker (NYSE:SYK) continued its acquisition spree yesterday with the purchase of SafeWire’s spine device line for an undisclosed amount. SafeWire’s Y-Wire guidewire and Tiger Jamshidi needle family are slated to join Stryker Spine’s portfolio of minimally invasive devices, the Kalamazoo, Mich.-based company said. “We are excited to bring this important complementary technology into the Stryker family,” Stryker […]